unithink Names John Cline CEO

By Unithink, PRNE
Sunday, December 5, 2010

New leader brings experience in CRO technology and corporate growth…

NIEL, Belgium and MORRISVILLE, North Carolina, December 6, 2010 - unithink NV announced that it has named John Cline CEO of the company.
Cline comes to unithink after successful stints at National Clinical Research
and etrials, where he was a founder and CEO.

While at etrials, Cline led the company through angel and venture funding
rounds that led to the successful IPO in February, 2006. A finalist for the
Ernst & Young Entrepreneur of the Year award in 2007, Cline was responsible
for leading the company operations for over six years and garnering a spot on
the Inc. 500 list of fastest growing privately held companies in the U.S.
etrials provides software used by drug companies and contract research
organizations in the running of clinical trials, and was acquired by Merge
Healthcare in 2009.

"John brings a wealth of experience in the CRO market that we need to
help position unithink as a leader in the market," said Anthony DeClerck,
Chairman at unithink. "In looking for a CEO, we wanted someone that
understood our clients and could grow our presences in the U.S. and
international markets. John is the ideal person to do just that."

Cline has over 25 years of experience in the pharmaceutical industry,
including senior sales and marketing roles at Organon Inc., Caremark, a
division of Baxter, and MiniDoc AB, a publicly held Swedish corporation. Mr.
Cline also served as President, CEO and director of Expidata Inc., which was
acquired by etrials in 2000. Cline is a graduate of the University of Georgia
with a BS, Journalism.

unithink was founded in 2005 as a small team providing solutions to
pharmaceutical and biotech clients on a "customised solutions per study"
basis with a clinical approach. Since then, unithink has grown into a
multi-national company with corporate headquarters at Waterfront Research
Park, Niel, Antwerp, Belgium, and with offices in India, Germany and the USA
at Research Triangle Park, North Carolina.

About unithink

unithink's unique approach, developed over the last 5 years, makes
eClinical software and techniques affordable and accessible for all
enterprises. unithink strives to help the world's most innovative
biopharmaceutical and medical device organizations bring much­needed medical
solutions to the market faster. Visit www.unithink.com or call
+32-3-298-00-57 in Europe; +1-919-328-5800 in the U.S.; or email

John Cline, +1-919-328-5810, john.cline at unithink.com

Clinical Trials / Medical Discoveries News

Western Europe News

will not be displayed